Molecular Simulations Inc.

Inspired by the looming problem of resistant organisms, and a Big Pharma exodus, start-ups are swarming into the anti-infectives field, confident that new technologies will bring them medical as well

Small companies are staking out niches where they think they can do a better job of turning hits into leads than Big Pharma. by Mary Stuart More than once, the nightly news has reported that a new dis

When is an active molecule a good drug? Companies are developing new screening tools to help them select drug-like candidates early in the drug discovery process. by Mary Stuart Structural design indu

From Sequence to Structure to Function and Back Again High-throughput gene sequencing efforts have been so successful, that now hundreds of thousands of gene sequences for proteins reside in public an